Selected research
Market Analysis & Forecast
Global DNA-Encoded Library Screening Services Market Analysis and Forecast 2026-2032
Market perspective
The global DNA-Encoded Library Screening Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for DNA-Encoded Library Screening Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for DNA-Encoded Library Screening Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for DNA-Encoded Library Screening Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for DNA-Encoded Library Screening Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of DNA-Encoded Library Screening Services include Pharmaron, Vipergen, Novalix, DyNAbind, MedChemExpress, BioDuro-Sundia, Charles River Laboratories, Chemspace and X-Chem, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for DNA-Encoded Library Screening Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of DNA-Encoded Library Screening Services, also provides the revenue of main regions and countries. Of the upcoming market potential for DNA-Encoded Library Screening Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the DNA-Encoded Library Screening Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA-Encoded Library Screening Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA-Encoded Library Screening Services revenue, projected growth trends, production technology, application and end-user industry.
DNA-Encoded Library Screening Services Segment by Company
Pharmaron
Vipergen
Novalix
DyNAbind
MedChemExpress
BioDuro-Sundia
Charles River Laboratories
Chemspace
X-Chem
HitGen
WuXi AppTec
DNA-Encoded Library Screening Services Segment by Type
Provider-Owned Library Screening
Client-Provided Library Screening
Custom-Built Library Screening
Consortium or Shared-Access Library Screening
DNA-Encoded Library Screening Services Segment by Application
Oncology Drug Discovery
Immunology and Inflammation Drug Discovery
Neurology Drug Discovery
Infectious Disease Drug Discovery
Metabolic and Cardiovascular Drug Discovery
Other Therapeutic Discovery
DNA-Encoded Library Screening Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA-Encoded Library Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA-Encoded Library Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA-Encoded Library Screening Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of DNA-Encoded Library Screening Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of DNA-Encoded Library Screening Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA-Encoded Library Screening Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Provider-Owned Library Screening
- Client-Provided Library Screening
- Custom-Built Library Screening
- Consortium or Shared-Access Library Screening
Applications
- Oncology Drug Discovery
- Immunology and Inflammation Drug Discovery
- Neurology Drug Discovery
- Infectious Disease Drug Discovery
- Metabolic and Cardiovascular Drug Discovery
- Other Therapeutic Discovery
Companies covered
- Pharmaron
- Vipergen
- Novalix
- DyNAbind
- MedChemExpress
- BioDuro-Sundia
- Charles River Laboratories
- Chemspace
- X-Chem
- HitGen
- WuXi AppTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 DNA-Encoded Library Screening Services Market by Type
- 1.2.1 Global DNA-Encoded Library Screening Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Provider-Owned Library Screening
- 1.2.3 Client-Provided Library Screening
- 1.2.4 Custom-Built Library Screening
- 1.2.5 Consortium or Shared-Access Library Screening
- 1.3 DNA-Encoded Library Screening Services Market by Application
- 1.3.1 Global DNA-Encoded Library Screening Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Oncology Drug Discovery
- 1.3.3 Immunology and Inflammation Drug Discovery
- 1.3.4 Neurology Drug Discovery
- 1.3.5 Infectious Disease Drug Discovery
- 1.3.6 Metabolic and Cardiovascular Drug Discovery
- 1.3.7 Other Therapeutic Discovery
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 DNA-Encoded Library Screening Services Market Dynamics
- 2.1 DNA-Encoded Library Screening Services Industry Trends
- 2.2 DNA-Encoded Library Screening Services Industry Drivers
- 2.3 DNA-Encoded Library Screening Services Industry Opportunities and Challenges
- 2.4 DNA-Encoded Library Screening Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global DNA-Encoded Library Screening Services Market Perspective (2021-2032)
- 3.2 Global DNA-Encoded Library Screening Services Growth Trends by Region
- 3.2.1 Global DNA-Encoded Library Screening Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global DNA-Encoded Library Screening Services Market Size by Region (2021-2026)
- 3.2.3 Global DNA-Encoded Library Screening Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global DNA-Encoded Library Screening Services Revenue by Players
- 4.1.1 Global DNA-Encoded Library Screening Services Revenue by Players (2021-2026)
- 4.1.2 Global DNA-Encoded Library Screening Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global DNA-Encoded Library Screening Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global DNA-Encoded Library Screening Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global DNA-Encoded Library Screening Services Key Players Headquarters & Area Served
- 4.4 Global DNA-Encoded Library Screening Services Players, Product Type & Application
- 4.5 Global DNA-Encoded Library Screening Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global DNA-Encoded Library Screening Services Market CR5 and HHI
- 4.6.3 2025 DNA-Encoded Library Screening Services Tier 1, Tier 2, and Tier 3
5 DNA-Encoded Library Screening Services Market Size by Type
- 5.1 Global DNA-Encoded Library Screening Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global DNA-Encoded Library Screening Services Revenue by Type (2021-2032)
- 5.3 Global DNA-Encoded Library Screening Services Revenue Market Share by Type (2021-2032)
6 DNA-Encoded Library Screening Services Market Size by Application
- 6.1 Global DNA-Encoded Library Screening Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global DNA-Encoded Library Screening Services Revenue by Application (2021-2032)
- 6.3 Global DNA-Encoded Library Screening Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Pharmaron
- 7.1.1 Pharmaron Company Information
- 7.1.2 Pharmaron Business Overview
- 7.1.3 Pharmaron DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Pharmaron DNA-Encoded Library Screening Services Product Portfolio
- 7.1.5 Pharmaron Recent Developments
- 7.2 Vipergen
- 7.2.1 Vipergen Company Information
- 7.2.2 Vipergen Business Overview
- 7.2.3 Vipergen DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.2.4 Vipergen DNA-Encoded Library Screening Services Product Portfolio
- 7.2.5 Vipergen Recent Developments
- 7.3 Novalix
- 7.3.1 Novalix Company Information
- 7.3.2 Novalix Business Overview
- 7.3.3 Novalix DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Novalix DNA-Encoded Library Screening Services Product Portfolio
- 7.3.5 Novalix Recent Developments
- 7.4 DyNAbind
- 7.4.1 DyNAbind Company Information
- 7.4.2 DyNAbind Business Overview
- 7.4.3 DyNAbind DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.4.4 DyNAbind DNA-Encoded Library Screening Services Product Portfolio
- 7.4.5 DyNAbind Recent Developments
- 7.5 MedChemExpress
- 7.5.1 MedChemExpress Company Information
- 7.5.2 MedChemExpress Business Overview
- 7.5.3 MedChemExpress DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.5.4 MedChemExpress DNA-Encoded Library Screening Services Product Portfolio
- 7.5.5 MedChemExpress Recent Developments
- 7.6 BioDuro-Sundia
- 7.6.1 BioDuro-Sundia Company Information
- 7.6.2 BioDuro-Sundia Business Overview
- 7.6.3 BioDuro-Sundia DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.6.4 BioDuro-Sundia DNA-Encoded Library Screening Services Product Portfolio
- 7.6.5 BioDuro-Sundia Recent Developments
- 7.7 Charles River Laboratories
- 7.7.1 Charles River Laboratories Company Information
- 7.7.2 Charles River Laboratories Business Overview
- 7.7.3 Charles River Laboratories DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Charles River Laboratories DNA-Encoded Library Screening Services Product Portfolio
- 7.7.5 Charles River Laboratories Recent Developments
- 7.8 Chemspace
- 7.8.1 Chemspace Company Information
- 7.8.2 Chemspace Business Overview
- 7.8.3 Chemspace DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Chemspace DNA-Encoded Library Screening Services Product Portfolio
- 7.8.5 Chemspace Recent Developments
- 7.9 X-Chem
- 7.9.1 X-Chem Company Information
- 7.9.2 X-Chem Business Overview
- 7.9.3 X-Chem DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.9.4 X-Chem DNA-Encoded Library Screening Services Product Portfolio
- 7.9.5 X-Chem Recent Developments
- 7.10 HitGen
- 7.10.1 HitGen Company Information
- 7.10.2 HitGen Business Overview
- 7.10.3 HitGen DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.10.4 HitGen DNA-Encoded Library Screening Services Product Portfolio
- 7.10.5 HitGen Recent Developments
- 7.11 WuXi AppTec
- 7.11.1 WuXi AppTec Company Information
- 7.11.2 WuXi AppTec Business Overview
- 7.11.3 WuXi AppTec DNA-Encoded Library Screening Services Revenue and Gross Margin (2021-2026)
- 7.11.4 WuXi AppTec DNA-Encoded Library Screening Services Product Portfolio
- 7.11.5 WuXi AppTec Recent Developments
8 North America
- 8.1 North America DNA-Encoded Library Screening Services Revenue (2021-2032)
- 8.2 North America DNA-Encoded Library Screening Services Revenue by Type (2021-2032)
- 8.2.1 North America DNA-Encoded Library Screening Services Revenue by Type (2021-2026)
- 8.2.2 North America DNA-Encoded Library Screening Services Revenue by Type (2027-2032)
- 8.3 North America DNA-Encoded Library Screening Services Revenue Share by Type (2021-2032)
- 8.4 North America DNA-Encoded Library Screening Services Revenue by Application (2021-2032)
- 8.4.1 North America DNA-Encoded Library Screening Services Revenue by Application (2021-2026)
- 8.4.2 North America DNA-Encoded Library Screening Services Revenue by Application (2027-2032)
- 8.5 North America DNA-Encoded Library Screening Services Revenue Share by Application (2021-2032)
- 8.6 North America DNA-Encoded Library Screening Services Revenue by Country
- 8.6.1 North America DNA-Encoded Library Screening Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America DNA-Encoded Library Screening Services Revenue by Country (2021-2026)
- 8.6.3 North America DNA-Encoded Library Screening Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe DNA-Encoded Library Screening Services Revenue (2021-2032)
- 9.2 Europe DNA-Encoded Library Screening Services Revenue by Type (2021-2032)
- 9.2.1 Europe DNA-Encoded Library Screening Services Revenue by Type (2021-2026)
- 9.2.2 Europe DNA-Encoded Library Screening Services Revenue by Type (2027-2032)
- 9.3 Europe DNA-Encoded Library Screening Services Revenue Share by Type (2021-2032)
- 9.4 Europe DNA-Encoded Library Screening Services Revenue by Application (2021-2032)
- 9.4.1 Europe DNA-Encoded Library Screening Services Revenue by Application (2021-2026)
- 9.4.2 Europe DNA-Encoded Library Screening Services Revenue by Application (2027-2032)
- 9.5 Europe DNA-Encoded Library Screening Services Revenue Share by Application (2021-2032)
- 9.6 Europe DNA-Encoded Library Screening Services Revenue by Country
- 9.6.1 Europe DNA-Encoded Library Screening Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe DNA-Encoded Library Screening Services Revenue by Country (2021-2026)
- 9.6.3 Europe DNA-Encoded Library Screening Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China DNA-Encoded Library Screening Services Revenue (2021-2032)
- 10.2 China DNA-Encoded Library Screening Services Revenue by Type (2021-2032)
- 10.2.1 China DNA-Encoded Library Screening Services Revenue by Type (2021-2026)
- 10.2.2 China DNA-Encoded Library Screening Services Revenue by Type (2027-2032)
- 10.3 China DNA-Encoded Library Screening Services Revenue Share by Type (2021-2032)
- 10.4 China DNA-Encoded Library Screening Services Revenue by Application (2021-2032)
- 10.4.1 China DNA-Encoded Library Screening Services Revenue by Application (2021-2026)
- 10.4.2 China DNA-Encoded Library Screening Services Revenue by Application (2027-2032)
- 10.5 China DNA-Encoded Library Screening Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia DNA-Encoded Library Screening Services Revenue (2021-2032)
- 11.2 Asia DNA-Encoded Library Screening Services Revenue by Type (2021-2032)
- 11.2.1 Asia DNA-Encoded Library Screening Services Revenue by Type (2021-2026)
- 11.2.2 Asia DNA-Encoded Library Screening Services Revenue by Type (2027-2032)
- 11.3 Asia DNA-Encoded Library Screening Services Revenue Share by Type (2021-2032)
- 11.4 Asia DNA-Encoded Library Screening Services Revenue by Application (2021-2032)
- 11.4.1 Asia DNA-Encoded Library Screening Services Revenue by Application (2021-2026)
- 11.4.2 Asia DNA-Encoded Library Screening Services Revenue by Application (2027-2032)
- 11.5 Asia DNA-Encoded Library Screening Services Revenue Share by Application (2021-2032)
- 11.6 Asia DNA-Encoded Library Screening Services Revenue by Country
- 11.6.1 Asia DNA-Encoded Library Screening Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia DNA-Encoded Library Screening Services Revenue by Country (2021-2026)
- 11.6.3 Asia DNA-Encoded Library Screening Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA DNA-Encoded Library Screening Services Revenue (2021-2032)
- 12.2 SAMEA DNA-Encoded Library Screening Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA DNA-Encoded Library Screening Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA DNA-Encoded Library Screening Services Revenue by Type (2027-2032)
- 12.3 SAMEA DNA-Encoded Library Screening Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA DNA-Encoded Library Screening Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA DNA-Encoded Library Screening Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA DNA-Encoded Library Screening Services Revenue by Application (2027-2032)
- 12.5 SAMEA DNA-Encoded Library Screening Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA DNA-Encoded Library Screening Services Revenue by Country
- 12.6.1 SAMEA DNA-Encoded Library Screening Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA DNA-Encoded Library Screening Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA DNA-Encoded Library Screening Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst